Literature DB >> 27441384

Conjugation and Evaluation of Triazole-Linked Single Guide RNA for CRISPR-Cas9 Gene Editing.

Kaizhang He1, Eldon T Chou1, Shawn Begay1, Emily M Anderson1, Anja van Brabant Smith2.   

Abstract

The CRISPR-Cas9 gene editing system requires Cas9 endonuclease and guide RNAs (either the natural dual RNA consisting of crRNA and tracrRNA or a chimeric single guide RNA) that direct site-specific double-stranded DNA cleavage. This communication describes a click ligation approach that uses alkyne-azide cycloaddition to generate a triazole-linked single guide RNA (sgRNA). The conjugated sgRNA shows efficient and comparable genome editing activity to natural dual RNA and unmodified sgRNA constructs.
© 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.

Entities:  

Keywords:  CRISPR-Cas9; conjugation; gene technology; oligonucleotides; single guide RNA

Mesh:

Substances:

Year:  2016        PMID: 27441384      PMCID: PMC5096024          DOI: 10.1002/cbic.201600320

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


The CRISPR‐Cas9 system has rapidly transitioned from an RNA‐guided defense system in bacteria to a remarkably effective and flexible technique for modifying the genome of higher eukaryotes, particularly in mammalian cells.1, 2, 3 In the most commonly used Streptococcus pyogenes type II CRISPR‐Cas9 system, the Cas9 (CRISPR‐associated 9) protein that cleaves the DNA is guided by two required small RNA sequences: the CRISPR RNA (crRNA), which binds the target DNA and guides cleavage, and the trans‐activating crRNA (tracrRNA), which base pairs with the crRNA and enables the Cas9–crRNA complex to form. A single RNA chimera, which combines the targeting specificity of the crRNA with the scaffolding properties of the tracrRNA, has been engineered to direct sequence‐specific dsDNA cleavage by Cas9.4 The single guide RNA (sgRNA), typically about 100 nucleotides (nt) long, can be generated by using a DNA vector expressing the sgRNA5, 6, 7 or by in vitro transcription (IVT).8 Both methods have a number of drawbacks, including time‐consuming cloning steps, unintended genome modifications from random integration of DNA plasmids encoding the sgRNA, and the complexity of generating high‐quality IVT material.9 An ideal alternative to an sgRNA expression plasmid or IVT‐generated sgRNA would be solid‐phase chemical synthesis. This method has the flexibility to quickly and accurately generate different sequences and lengths of RNA without the need for multiple cloning and sequencing steps. Although long RNAs (length around 100 nt) can be prepared by using automated, solid‐phase oligonucleotide synthesis machines with 2′‐acetoxyethyl orthoester (2′‐ACE)10, 11 or 2′‐thionocarbamate (2′‐TC) chemistry,12, 13 effective and efficient synthesis of hundreds of high quality long RNAs with lengths of ∼100 nt is still a challenge when considering yield, purity, and cost. An alternative approach to the synthesis of larger oligonucleotide strands is to combine solid‐phase synthesis with chemical ligation; for example, a click chemistry approach can be applied in which copper(I)‐catalyzed alkyneazide cycloaddition (CuAAC) is used for the synthesis of very long oligodeoxyribonucleotides (DNAs).14, 15 Another benefit of using chemical ligation to conjugate crRNA and tracrRNA is the possibility of incorporating chemical modifications to the conjugation site. The CRISPR‐Cas9 gene editing system holds tremendous therapeutic potential to treat unmet medical needs, and chemical modifications of synthetic sgRNA are likely required to improve the stability and pharmacokinetic properties. Modifications including phosphorothioates, 2′‐OMe, 2′‐F, 2′‐constrained ethyl (2′‐cEt), and/or 2′‐OMe 3′‐thioPACE were applied to regions of the crRNA that recognize their DNA targets or to the tracrRNA anti‐repeat region and were found to increase the efficiency of gene disruption compared to unmodified crRNA.13, 16 We now report a solid‐phase synthesis strategy for ligating two oligoribonucleotides (RNAs) by using the CuAAC reaction to assemble a long sgRNA containing a triazole linkage. This approach for generation of chemically synthesized sgRNAs has several desirable features and potentials: it is easy to carry out, other conjugation chemistries (i.e., amine–NHS, thiol–maleimide, and hydrazine–oxime) can also be used, and it is applicable to the synthesis of libraries of sgRNAs. We also envisage that the conjugation methodology presented here will be invaluable for the synthesis of highly modified sgRNAs with complex structures (i.e., incorporation of an N‐acetylgalactosamine [GalNAc] moiety for delivery17 or conjugation of fluorescent dyes for imaging18). Various bioconjugation reactions can be used to ligate two oligonucleotides.19 One widely utilized method is the Huisgen 1,3‐dipolar cycloaddition reaction involving an alkyne and azide to yield a highly stable triazole linker. The ligation reaction is fast, efficient, specific, and compatible with aqueous media.20, 21 To synthesize the long conjugated sgRNA containing a triazole linker (Scheme 1), we designed a 5′‐hexyne tracrRNA (tracr‐1, 65‐mer), based on the published S. pyogenes tracrRNA sequence,4 and a 3′‐azide crRNA component (cr‐1, 34‐mer; Table 1). The requisite 5′‐hexyne‐tracrRNA protected with 2′‐ACE was prepared by incorporating a 5′‐hexyne phosphoramidite monomer in the final coupling step to the solid support‐bound RNA, synthesized by 2′‐acetoxyethyl orthoester (2′‐ACE) chemistry. The 34‐nt crRNA was designed by appending part of the S. pyogenes crRNA repeat sequence, 5′‐GUUUUAGAGCUAGA‐3′, to the 20‐mer target/spacer sequence (GUGUAUUUUGACCUACGAAU) targeting human peptidylprolyl isomerase B (PPIB). The corresponding 3′‐azide‐crRNA, protected with 2′‐ACE, was synthesized from the reaction of azidoacetic acid NHS ester with HPLC‐purified 3′‐aminohexyl‐modified RNA (cr‐3 with 2′‐ACE). The 3′‐azide‐labeled crRNA was desalted and further purified by reverse‐phase HPLC.
Scheme 1

Synthesis of triazole‐linked single guide RNA (sgRNA) (sg‐1).

Table 1

RNA oligonucleotides used in this study.

CodeSequence (5′–3′)nt lengthMS calcdMS found
tracr‐15′‐hexyne‐AAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUU‐3′6521 080.721 082.3
tracr‐25′‐AAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUU‐3′6520 920.720 918.3
cr‐15′‐GUGUAUUUUGACCUACGAAUGUUUUAGAGCUAGA‐C6‐N3‐3′3411 126.011 127.0
cr‐25′‐GUGUAUUUUGACCUACGAAUGUUUUAGAGCUAGA‐3′3410 863.510 862.2
cr‐35′‐GUGUAUUUUGACCUACGAAUGUUUUAGAGCUAGA‐C6‐NH2‐3′3410 988.610 990.4
sg‐15′‐GUGUAUUUUGACCUACGAAUGUUUUAGAGCUAGA‐L‐AAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUC‐9932 192.532 225.1
 AACUUGAAAAAGUGGCACCGAGUCGGUGCUUU‐3′
sg‐25′‐GUGUAUUUUGACCUACGAAUGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAA‐9931 846.231 863.8
 CUUGAAAAAGUGGCACCGAGUCGGUGCUUU‐3′

Products were characterized by MS (ESI−). L is:

Synthesis of triazole‐linked single guide RNA (sgRNA) (sg‐1). RNA oligonucleotides used in this study. Products were characterized by MS (ESI−). L is: The CuI‐catalyzed ligation reaction between 2′‐ACE‐protected 5′‐hexyne‐tracrRNA and 3′‐azide‐crRNA in aqueous solution was conducted on a 50 nmol scale. The resulting conjugated sgRNA was precipitated with acetone. The RNA pellet was washed, dried, and purified by reverse‐phase HPLC. The 2′‐ACE groups on the conjugated sgRNA were removed according to a standard Dharmacon protocol,10, 11 and the triazole‐linked sgRNA (sg‐1) was desalted by ethanol precipitation. To investigate and compare the efficiency of genome editing by the synthetic conjugated sgRNA (sg‐1), we also synthesized a natural 65‐mer tracrRNA (tracr‐2), 34‐mer crRNA (cr‐2), and 99‐mer sgRNA (sg‐2) by using 2′‐ACE chemistry (Table 1). A T7E1 mismatch detection assay was used to detect and quantify insertions and deletions (indels) that were created by repair of the CRISPR‐Cas9‐induced double strand break through the non‐homologous end joining repair pathway. As shown in Figure 1, transfection of sg‐1 into a U2OS cell line that stably expresses Cas9 results in indels at the PPIB‐targeted site. The level of gene disruption (>40 % cleavage) is comparable to that of the natural dual RNA system with two RNAs (cr‐2 and tracr‐2). After replacing the phosphodiester bond with a long linker containing the triazole linkage (Scheme 1), the conjugated sgRNA (sg‐1) retained high indel frequency, comparable to the natural 99‐mer sgRNA (sg‐2). A recent study identified and characterized six conserved modules (spacer, lower stem, upper stem, bulge, nexus, and hairpin) within native crRNA: tracrRNA duplexes and sgRNAs that direct Cas9 endonuclease activity; the bulge and nexus are the most critical features for Cas9 targeting.21 Compared to the native 99‐mer sgRNA, the triazole‐linked sgRNA has an additional 20‐atom linkage replacing the phosphodiester bond (Scheme 2). The linkage is located at the loop structure of the upper stem; this structure was suggested to be non‐essential for CRISPR‐Cas9 functionality.22, 23 Our gene editing results confirmed that changing or extending the loop structure with a non‐natural linkage did not have a significant effect on knockout efficiency.
Figure 1

Gene editing by using synthetic RNAs. Transfection of a synthetic sgRNA 99‐mer (sg‐2), conjugated sgRNA 99‐mer (sg‐1), or synthetic crRNA (34‐mer, cr‐2) and tracrRNA (65‐mer, tracr‐2) results in targeted DNA cleavage in Cas9‐expressing U2OS cells. Stable Cas9‐expressing cells were generated by using Cas9 lentivirus. Cells were transfected with the sgRNA or dual crRNA and tracrRNA and compared to untransfected cells (UT) by using the T7 endonuclease I (T7EI) mismatch detection assay. The percent edited after 72 h is indicated at the bottom of each lane.

Scheme 2

sgRNA sequences and functional modules: A) Natural sgRNA (sg‐2) with native phosphodiester bond; B) Conjugated sgRNA (sg‐1) with triazole linker.

Gene editing by using synthetic RNAs. Transfection of a synthetic sgRNA 99‐mer (sg‐2), conjugated sgRNA 99‐mer (sg‐1), or synthetic crRNA (34‐mer, cr‐2) and tracrRNA (65‐mer, tracr‐2) results in targeted DNA cleavage in Cas9‐expressing U2OS cells. Stable Cas9‐expressing cells were generated by using Cas9 lentivirus. Cells were transfected with the sgRNA or dual crRNA and tracrRNA and compared to untransfected cells (UT) by using the T7 endonuclease I (T7EI) mismatch detection assay. The percent edited after 72 h is indicated at the bottom of each lane. sgRNA sequences and functional modules: A) Natural sgRNA (sg‐2) with native phosphodiester bond; B) Conjugated sgRNA (sg‐1) with triazole linker. In summary, we report the first CRISPR‐Cas9 system with a synthetic conjugated sgRNA with efficient gene knockout functionality. Our results indicate that the nucleotides in the loop structure of the upper stem in the crRNA:tracrRNA duplex are not essential for CRISPR‐Cas9 targeting and open up the possibility of modifying the loop structure with unnatural linkages by conjugating modified crRNA and tracrRNA. This approach would not necessarily be limited to the triazole linker reported here, and alternative conjugation chemistries19, 21 and the resulting linkers (amide, disulfide, thioester, hydrozone, etc.) might also be suitable for forming new conjugated sgRNA molecules. Furthermore, the ability to synthesize conjugated sgRNAs by using a 5′‐end‐modified tracrRNA and altered crRNAs (3′‐end‐modified) with different sequences targeting multiple genes opens new avenues for generating long sgRNA libraries in array or plate formats. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Supplementary Click here for additional data file.
  22 in total

1.  New strategy for the synthesis of chemically modified RNA constructs exemplified by hairpin and hammerhead ribozymes.

Authors:  Afaf H El-Sagheer; Tom Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

2.  CASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells.

Authors:  Wulan Deng; Xinghua Shi; Robert Tjian; Timothée Lionnet; Robert H Singer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

3.  Streamlined process for the chemical synthesis of RNA using 2'-O-thionocarbamate-protected nucleoside phosphoramidites in the solid phase.

Authors:  Douglas J Dellinger; Zoltán Timár; Joel Myerson; Agnieszka B Sierzchala; John Turner; Fernando Ferreira; Zoltán Kupihár; Geraldine Dellinger; Kenneth W Hill; James A Powell; Jeffrey R Sampson; Marvin H Caruthers
Journal:  J Am Chem Soc       Date:  2011-07-11       Impact factor: 15.419

Review 4.  Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.

Authors:  Jennifer L Gori; Patrick D Hsu; Morgan L Maeder; Shen Shen; G Grant Welstead; David Bumcrot
Journal:  Hum Gene Ther       Date:  2015-07       Impact factor: 5.695

5.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.

Authors:  Seung Woo Cho; Sojung Kim; Jong Min Kim; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

6.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.

Authors:  Ayal Hendel; Rasmus O Bak; Joseph T Clark; Andrew B Kennedy; Daniel E Ryan; Subhadeep Roy; Israel Steinfeld; Benjamin D Lunstad; Robert J Kaiser; Alec B Wilkens; Rosa Bacchetta; Anya Tsalenko; Douglas Dellinger; Laurakay Bruhn; Matthew H Porteus
Journal:  Nat Biotechnol       Date:  2015-06-29       Impact factor: 54.908

7.  Crystal structure of Cas9 in complex with guide RNA and target DNA.

Authors:  Hiroshi Nishimasu; F Ann Ran; Patrick D Hsu; Silvana Konermann; Soraya I Shehata; Naoshi Dohmae; Ryuichiro Ishitani; Feng Zhang; Osamu Nureki
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

8.  Click chemistry beyond metal-catalyzed cycloaddition.

Authors:  C Remzi Becer; Richard Hoogenboom; Ulrich S Schubert
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

9.  Solid phase click ligation for the synthesis of very long oligonucleotides.

Authors:  Jieqiong Qiu; Afaf H El-Sagheer; Tom Brown
Journal:  Chem Commun (Camb)       Date:  2013-08-11       Impact factor: 6.222

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

View more
  3 in total

Review 1.  CRISPR-derived genome editing therapies: Progress from bench to bedside.

Authors:  Holly A Rees; Alex C Minella; Cameron A Burnett; Alexis C Komor; Nicole M Gaudelli
Journal:  Mol Ther       Date:  2021-10-05       Impact factor: 11.454

2.  Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.

Authors:  Hao Yin; Chun-Qing Song; Sneha Suresh; Suet-Yan Kwan; Qiongqiong Wu; Stephen Walsh; Junmei Ding; Roman L Bogorad; Lihua Julie Zhu; Scot A Wolfe; Victor Koteliansky; Wen Xue; Robert Langer; Daniel G Anderson
Journal:  Nat Chem Biol       Date:  2018-01-29       Impact factor: 15.040

3.  An artificial triazole backbone linkage provides a split-and-click strategy to bioactive chemically modified CRISPR sgRNA.

Authors:  Lapatrada Taemaitree; Arun Shivalingam; Afaf H El-Sagheer; Tom Brown
Journal:  Nat Commun       Date:  2019-04-08       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.